Pfizer Lowers Targeted Revenues for 2012; Wall Street Remains Skeptical

Pfizer's touts growth plans in emerging markets as the pharma prepares for the onset of Lipitor generics.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet